Treatment of insomnia in substance abusing patients

Psychiatric Annals

Volumn 28, Issue 3, 1998, Pages 154-159

  Longo, Lance P ^a,b,d   Johnson, Brian ^c  

^a AURORA SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c Bournewood Hospital   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032372707     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19980301-11     Document Type: Article

References (41)

1. Hauri J, Orr WC. Sleep disorders, 2nd edn. Kalamazoo, Michigan: The Upjohn Co; 1982.
2. Olson WH, Brumack RA, Lyer V, Gascon G. Sleep disorders. In: Handbook of Symptom Oriented Neurology. Chicago: Yearbook Medical Publishers; 1989:64-79.
3. Mellinger GO, Alter MB, Uhlenhuth EH. Insomnia and its treatment: prevalence and correlates. Arch Gen Psychiatry. 1985;42:225-32.
4. Gillin JO, Byerley WE. The diagnosis and management of insomnia. N Engl J Med. 1990; 322:4:239-248.
5. Drugs and insomnia: the use of medications to promote sleep. JAMA, Report of NIH Consensus Conference. 1984;251:2410-2414.
6. Gillin JC, Spinweber CL, Johnson LC. Rebound insomnia: a critical review. Clin Psychopharmacol. 1989;9:161-72.
7. Kales A, Kales JO. Evaluation and Treatment of Insomnia. New York: Oxford University Press; 1984.
8. Ashton H. Protracted withdrawal syndromes from benzodiazepines. J Subst Abuse Treat. 1991;8:19-28.
9. Hauri P, Sataia MJ. Nonpharmacologic treatment of sleep disorders. In: Hales RE, Frances AJ eds. Psychiatry Update: American Psychiatric Association Annual Review, vol. 4. Washington, DC: American Psychiatric Press; 1985:361-378.
10. Johnson B. A developmental model of addictions, and its relationship to the twelve step program of Alcoholics Anonymous. J Subst Abuse Treat. 1993;10:23-32.
11. Johnson B. The psychoanalysis of a man with active alcoholism. J Subst Abuse Treatment. 1992;9:111-23.
12. Janicak PG, Davis JM, Preskhorn SH, Ayd FJ. In: Principles and Practice of Psychopharmacotherapy. Baltimore: Williams and Wilkins; 1993:425-429.
13. Hypnotic drugs. Med Lett. 1996;38:59-61.
14. Greenblatt DJ. Pharmacology of benzodiazepine hypnotics. J Clin Psychiatry. 1992;53(suppl 6):7-13.
15. Bootzin R, Laymeyer H, Lillie J. Pharmacologic interventions in sleep disorders. In: Integrated Approach to Sleep Management. New York: Cahners Healthcare Communications, Excerpts Medica, Inc; 1994:25-28.
16. Walsh OK, Hartman PG, Kowall JP. Insomnia. In: Ghakroverty S. ed. Sleep Disorders Medicine: Basic Science, Technical Considerations, and Clinical Aspects. Boston; Butterworth-Heinemenan; 1994:219-239.
17. Kripke OF, Hauri P, Roth T. Sleep evaluation in chronic insomnia during short and long term use of two benzodiazepines, flurazepam and midazolam. Sleep Res. 1987; 16:99.
18. Mamelak M, Adele C, Buck L, et al. A comparative study of the effects of brotizolam and flurazepam on sleep and performance in the elderly. J Clin Psychopharmacol. 1989;9:260-267.
19. Mamelak M, Csima A, Price V. A comparative 25-night sleep laboratory study on the effects of quezepam and triazolam on the sleep of chronic insomniacs. J Clin Pharmacy. 1984;24:65-75.
20. Kales A, Soldatos CR, Vela-Bueno A. Clinical comparison of benzodiazepine hypnotics with short and long elimination of half lives. In: Smith DE, Wesson DR, eds. The Benzodiazepines. Current standards for medical practice. Lancaster, Pennsylvania: MTP Press Limited; 1986.
21. Kales A, Bixler ED, Vela-Bueno A, et al. Comparison of short and long half life benzodiazepine hypnotics: triazolam and quazepam. Clin Pharmacol Ther. 1986;40:378-386.
22. Schneider-Helmert O. Why low-dose benzodiazepine-dependent insomniacs can't escape their sleeping pills. Acta Psychiatry Scand. 1988;78:706-711.
23. Lucki I, Rickels R, Geller AM. Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacology. 1986;88:416-433.
24. Miller NS, Gold MS. Introduction - benzodiazepines: a major problem. J Subst Abuse Treat. 1991;8:3-7.
25. Winokur A, Reynolds CF. The effects of antidepressants on sleep physiology. Primary Psychiatry. 1994;1 Suppl 1-6.
26. Nicholson AN, Pascoe PA. Studies on the modulation of the sleep-wakefulness continuum in man by fluoxetine, a 5-HT uptake inhibitor. Neuropharmacology. 1988;27:597-602.
27. Schenck CH, Mahowald MW, Kim SW, O'Connor KA, Hurwitz TO. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep. 1992;15:226-235.
28. Saletu B, Frey R, Krupka M, Anderer P, Grunberger J, See WR. Sleep: Laboratory studies on the single dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities. Sleep. 1991;14:439-447.
29. Shipley JE, Kupfer DJ, Griffin SJ, et al. Comparison of effects of desipramine and amitriptyline on EEG sleep of depressed patients. Psychopharmacology. 1985;56:14-22.
30. Minot R, Luthringer R, Macher JP. Effect of moclobemide on the psychophysiology of sleep-wake cycles: a neuroelectrophysiological study of depressed patients administered with moclobemide. Int Clin Psychopharmacol. 1993;7:181-189.
31. Reynolds CF III, Buysse DJ, Nofzinger EA, Kupfer DJ. Treatment of persistent insomnia in psychiatric patients: effects of antidepressant therapies on sleep in mood disorders. In: Schatzberg A, ed. Textbook of Psychopharmacology. Washington, DC: ADA Press; 1994.
32. Rascati K. Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medications. Clin Therapeutics. 1995;17:4:786-790.
33. Nierenberg A, et al. Am J Psychiatry. 1994;151:1069.
34. Annitage R, Trivadi M, Cain J, Roffwarg HP. The effects of nefazadone on sleep architecture in depression. Neuropsychopharmacology. 1994;10:123-127.
35. Sharpley AI, Walsh AES, Gowen PJ. Nefazadone - a novel antidepressant - may increase REM Sleep. Biol Psychiatry. 1992;31:1070-1073.
36. Ambien. In: Physicians' Desk Reference, 48th ed. Montrale, New Hampshire: Medical Economics Data Production Co; 1994:2189-2192.
37. Zolpidem for insomnia. Med Lett. 1993;35(895)35-36.
38. Licciardello L, Licini P. Safety and efficacy of zolpidem therapy in sleep disorders: a multicenter trial in hospitalized patients. Curr Ther Res Clin Exp. 1992;52:652-658.
39. Markowitz J, Brewerton T. Zolpidem-induced psychosis. Ann Clin Psychiatry. 1996;8:89-91.
40. Melatonin. Med Lett. 1995;37:962.
41. Schneider-Helmert D, Spinweber CL. Evaluations of L-tryptophan for treatment of insomnia: a review. Psychopharmacology. (Berlin) 1986;89:1-7.